Cara Therapeutics
CARA
$0.69
Share price
-5.72%
Change (1 day)
-84.42%
Change (1 year)
Categories
Cara Therapeutics (CARA) - Cash on Hand
Cash on Hand as of December 2023 : $0.10 B
According to Cara Therapeutics
's latest financial reports the company has $0.10 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Cara Therapeutics - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.10 B | -30.7% |
| 2022-12-31 | $0.14 B | -12.95% |
| 2021-12-31 | $0.16 B | -7.68% |
| 2020-12-31 | $0.18 B | 16.72% |
| 2019-12-31 | $0.15 B | -3.95% |
| 2018-12-31 | $0.16 B | 74.34% |
| 2017-12-31 | $92.56 M | 58.85% |
| 2016-12-31 | $58.27 M | -45.4% |
| 2015-12-31 | $0.10 B | 102.69% |
| 2014-12-31 | $52.66 M | 326.18% |
| 2013-12-31 | $12.35 M | 1006.27% |
| 2012-12-31 | $1.11 M | -72.74% |
| 2011-12-31 | $4.09 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 22,654.52% | 🇺🇸 USA |
 Pfizer PFE | $12.69 B | 12,494.53% | 🇺🇸 USA |
 Trevena TRVN | $34.95 M | -65.31% | 🇺🇸 USA |
 Recro Pharma
REPH | N/A | N/A | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | N/A | N/A | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $32.46 M | -67.78% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $9.38 M | -90.69% | 🇺🇸 USA |